Recent Articles from GlobeNewswire

CHEYENNE, WY, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Next Technology Holding Inc. (NASDAQ: NXTT) (the “Company”), a technology company focused on AI-powered software development and digital asset management, today announced that its Board of Directors (the “Board”) unanimously approved, by written consent effective October 30, 2026, the sale or pledging of the Company’s Bitcoin holdings in one or more tranches. As of October 30, 2026, the Company held approximately 5,833 Bitcoin. The Board determined that a timely adjustment of the Company’s digital asset position is in the best interests of the Company and its stockholders, with the aim of reducing risk exposure and enhancing liquidity.

PISCATAWAY, N.J., Oct. 30, 2026 (GLOBE NEWSWIRE) -- BHAV Acquisition Corp II (the “Company” or “BHAV”) today announced the closing of its previously announced initial public offering of 10,000,000 units (the “Offering”) at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one right. Each right entitles the holder to receive one-fourth (1/4) of one Class A ordinary share upon consummation of the Company’s initial business combination. The units began trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “BHAIU” on October 29, 2026. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to trade on Nasdaq under the symbols “BHAI” and “BHAIR,” respectively.

MALVERN, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today announced that on October 29, 2026, it received notice (the “Notice”) from the New York Stock Exchange (NYSE) that it is no longer in compliance with the NYSE continued listing standards set forth in Section 802.01B of the NYSE’s Listed Company Manual due to the fact that the Company’s average market capitalization over a consecutive 30 trading-day period was less than $50 million while its stockholders’ equity was less than $50 million.

BEIJING, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Origin Agritech Limited (NASDAQ: SEED) ("Origin" or the "Company"), a leading Chinese agricultural technology company, today announced that on October 27, 2026, it received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") stating that, for the last 30 consecutive business days, the closing bid price of the Company’s ordinary shares had been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement").

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the third quarter ended September 30, 2026 on Monday, November 9, 2026 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Tuesday, November 10, 2026 at 12:00 p.m. Eastern Time to discuss its third quarter ended September 30, 2026 financial results.

ROCKVILLE, Md., Oct. 30, 2026 (GLOBE NEWSWIRE) -- X-Energy, Inc. (Nasdaq: XE) (“X-energy” or the “Company”), a leading designer of advanced nuclear reactor technology and manufacturer of nuclear fuels, today announced it plans to report third quarter 2026 financial results and operational highlights on Thursday, November 12, 2026. A press release will be issued before markets open.

Automobile And Transportation Veteran To Support Continued H&A Integration And Additional Opportunities For Growth

HONG KONG, Oct. 31, 2026 (GLOBE NEWSWIRE) -- Here Group Limited (NASDAQ: HERE) (“Here” or the “Company”), an IP-based pop toy company dedicated to creating beloved collectibles and trend-defining experiences, today announced that it filed its annual report on Form 20-F for the fiscal year ended June 30, 2026, with the Securities and Exchange Commission on October 30, 2026. The annual report on Form 20-F can be accessed on the SEC's website at http://www.sec.gov and on the Company's investor relations website at https://ir.heregroup.com/financials-filings/annual-reports.

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- MidCap Financial Investment Corporation (NASDAQ: MFIC) (the “Company”) announced today that, in light of entering into a definitive merger agreement (the “Merger Agreement”) with Ares Capital Corporation (NASDAQ: ARCC) (“ARCC”), under which ARCC will acquire the Company (the “Transaction”), it will not hold the third quarter 2026 earnings conference call and webcast previously scheduled for Thursday, November 5, 2026, at 8:30 a.m. Eastern Time.

KING OF PRUSSIA, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the UBS Global Healthcare Conference on November 10, 2026, at 9:30 a.m. Eastern Time.

Increased Revenue 9% year-over-year to $205.6 million, driven by Social and CTV Growth

JUPITER, Fla., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional input proteins for use in life sciences, food and nutrition, and industrial biotechnology applications utilizing its proprietary gene expression platforms, today announced that it will report its financial results for the quarter ended September 30, 2026 and host a corporate update conference call on Thursday, November 12, 2026.

Keynote panel with SVP of Healthcare Paul F. Soczynski and Grace Li of On Lok covered growth, outcomes, regulation and the need for state-by-state advocacy

CALGARY, Alberta, Oct. 30, 2026 (GLOBE NEWSWIRE) -- De Havilland Canada (DHC) is pleased to announce that the company has entered into an agreement with the Government of Canada and Export Development Canada (EDC) that will allow the company to double De Havilland Canadair 515 (DHC-515) production.

VANCOUVER, BC and BOSTON, MA, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to nine new non-officer employees consisting of an aggregate of 24,250 share options and 14,250 restricted share units (RSUs). All of the foregoing share options and RSUs were approved by the Compensation Committee of the Company’s Board of Directors with an effective date of October 29, 2026 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced U.S. commercial availability of the HyperVue Integrated System1, a new single room-based configuration of its HyperVue Imaging System for DeepOCT+NIRS imaging and X1-FFR physiology assessment. It is designed to keep advanced coronary imaging and physiology tools connected and readily available in the interventional suite. The system will be showcased at TCT 2026 in San Diego, California, October 31–November 3, alongside Philips’ broader portfolio of imaging, physiology and procedural guidance solutions for precision PCI.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In O-I Glass To Contact Him Directly To Discuss Their Options

Enhanced facility surveillance, connected transportation oversight, and documented customer-specific procedures reinforce protection of sensitive equipment from pickup through final destruction

PARSIPPANY, N.J., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Atlas Copco Group has completed Expansion Week US, a coordinated series of openings and expansion announcements highlighting three strategic investments in US manufacturing.

Department of Homeland Security, et al. v. D.V.D., et al.

WILMINGTON, Mass., Oct. 30, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of UniFirst Corporation (NYSE:UNF) today declared increased quarterly cash dividends of $0.375 per share (37.5 cents) on the Company's Common Stock and $0.300 per share (30.0 cents) on the Company's Class B Common Stock. Both dividends are payable on December 15, 2026 to shareholders of record on November 13, 2026.

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Gildan Activewear Inc. (“Gildan” or the “Company”) (NYSE: GIL) on behalf of investors that purchased or otherwise acquired Gildan securities between February 19, 2025 and June 15, 2026 (the “Class Period”).

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Duolingo, Inc. (“Duolingo” or the “Company”) (NASDAQ: DUOL) on behalf of investors that purchased or otherwise acquired Duolingo Class A common stock between May 2, 2025 and February 26, 2026 (the “Class Period”).

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Bank of America Corporation (“Bank of America” or the “Company”) (NYSE: BAC) on behalf of investors that purchased or otherwise acquired Bank of America common stock between August 1, 2025 and October 13, 2026 (the “Class Period”).

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Millrose Properties, Inc. (“Millrose” or the “Company”) (NYSE: MRP) on behalf of investors that purchased or otherwise acquired Millrose securities between February 7, 2025 and October 2, 2026 (the “Class Period”).

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Coastal Financial Corporation (“Coastal Financial” or the “Company”) (NASDAQ: CCB) on behalf of investors that purchased or otherwise acquired Coastal Financial common stock between October 28, 2024 and July 29, 2026 (the “Class Period”).

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Alphabet Inc. (“Alphabet” or the “Company”) (NASDAQ: GOOGL, GOOG) on behalf of investors that purchased or otherwise acquired Alphabet securities between May 19, 2026 and July 16, 2026 (the “Class Period”).

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against AppLovin Corporation (“AppLovin” or the “Company”) (NASDAQ: APP) on behalf of investors that purchased or otherwise acquired AppLovin securities between February 12, 2026 and August 5, 2026 (the “Class Period”).

ATEC’s stock recently dropped more than 35%; Ademi LLP is investigating Alphatec for potential securities fraud.

Residential milestone underscores strong demand for the 70-story Long Island City tower, with more than 750 units leased since January amid New York City’s competitive rental market

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DICK’s Sporting Goods, Inc. (“Dick’s Sporting Goods” or the “Company”) (NYSE: DKS) on behalf of investors that purchased or otherwise acquired Dick’s Sporting Goods common stock between September 8, 2025 and August 24, 2026 (the “Class Period”).

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the “Class Period”).

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the “Class Period”).

Launch Partners BD and Merck recognized for inaugural contributions as CMMB expands its capacity to deliver essential medicines and medical supplies worldwide

Survey report uncovers businesses with formal accounts payable payment strategies modernize payments, increase financial value, and improve strategic decision-making

Building career pathways, fostering mentorship and empowering young adults transitioning out of foster care through continued partnership with TRAC

DUBLIN, Oct. 30, 2026 (GLOBE NEWSWIRE) -- For a business traveller, landing often means getting straight back to work: downloading a presentation or replying to a client. Without mobile data, the airport’s free Wi-Fi is often the easiest way to get online, but it can be slow and risky. So the employee connects and watches, frustrated, as the progress bar barely moves.

New capability helps members seamlessly move recurring payments to their Global Credit Union cards while strengthening digital engagement and financial relationships

Top Honors Awarded to ComEd, National Grid, Southern Company, TS Conductor, and Veolia

Achiever Magazine profile highlights Ricci’s multidisciplinary approach to leadership, long-term wealth planning and meaningful professional impact.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

NOT FOR RELEASE, DISSEMINATION, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

Bezos Earth Fund, Andes Amazon Fund, Nia Tero, and Rainforest Trust join forces to support Guyana’s 30x30 ambitions, including the proposed permanent protection of of over 1 million hectares (2.4 million acres) of the Acarai–Rupununi Corridor

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Coastal Financial Corporation (“Coastal” or “the Company”) (NASDAQ: CCB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Duolingo, Inc. (“Duolingo” or “the Company”) (NASDAQ: DUOL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fluence Energy, Inc. (“Fluence” or “the Company”) (NASDAQ: FLNC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Endava plc (“Endava” or “the Company”) (NYSE: DAVA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Webull Corporation (“Webull” or “the Company”) (NASDAQ: BULL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Compass, Inc. (“Compass” or “the Company”) (NYSE: COMP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Qfin Holdings, Inc. (“Qfin” or “the Company”) (NASDAQ: QFIN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) --

Xylem's new 2026 adjusted EPS ceiling of $5.45 now sits below the $5.55 floor it replaced. An investigation into potential securities law violations is reviewing losses suffered by XYL shareholders

The partnership combines ACS’s Bullfrog autonomous weapon station with CX2’s RF sensing and electronic warfare technology to advance layered counter-UAS defense solutions

Following a challenge brought by GuruNanda, LLC, BBB National Programs’ National Advertising Division reviewed advertising claims made by Davids Health Sciences, Inc. for its Pulling Oil Oral Rinse, including claims regarding certain of the product’s oral health benefits and a claim that the product is “Proudly made in USA.”

Following a challenge by The Procter & Gamble Company (P&G), BBB National Programs’ National Advertising Division determined that Clutch, Inc. d/b/a Carpe provided a reasonable basis for the $19.95 reference price used in its Underarm Stick savings claims, but recommended that Carpe modify or discontinue other challenged advertising, including savings, free shipping, comparative performance, and “first” 100-hour sweat and odor control claims.

NEWPORT NEWS, Va., Oct. 30, 2026 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today the appointment of Renee Swan to executive vice president and chief human resources officer (CHRO), effective Dec. 7, 2026. Swan comes to HII from Nashville-based Atmus Filtration Technologies (NYSE: ATMU), where she served as senior vice president and chief people officer.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against D-Wave Quantum Inc. (“D-Wave” or “the Company”) (NASDAQ: QBTS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Millrose Properties, Inc. (“Millrose” or “the Company”) (NYSE: MRP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bank of America Corporation (“Bank of America” or “the Company”) (NYSE: BAC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gildan Activewear Inc. (“Gildan” or “the Company”) (NYSE: GIL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Ingelheim, Germany and Ridgefield, Conn., U.S. - Boehringer Ingelheim today announced the registration of the Phase III AIRWARD™ trial evaluating its investigational oral therapy verducatib as a treatment option targeting DPP1 in adults with COPD; the trial was published on ClinicalTrials.gov (NCTXXXXXX).1 The trial will evaluate verducatib, an investigational dipeptidyl peptidase 1 (DPP1) inhibitor, in adults who continue to experience exacerbations, despite treatment with their usual therapy, and have a blood eosinophil count below 300 cells/µL.1 Building on more than 100 years of heritage in respiratory medicine and extensive experience in COPD, Boehringer is committed to addressing the needs of people who continue to experience exacerbations while receiving standard of care.

BALA CYNWYD, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

The 16th China Photography Festival

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that AVLAYAH® (tividenofusp alfa-eknm) has been recognized as the “Best Biotechnology Product” of 2026 by The Galien Foundation. AVLAYAH is the first biologic approved by the U.S. Food and Drug Administration (FDA) that is specifically designed to cross the blood-brain barrier and reach the whole body, including the brain. AVLAYAH is an enzyme replacement therapy that received FDA accelerated approval in March 2026 for the treatment of neurologic manifestations of a rare neurodegenerative disease called Hunter syndrome (mucopolysaccharidosis type II, or MPS II) when initiated in presymptomatic or symptomatic pediatric patients weighing at least 5 kg prior to advanced neurologic impairment. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory study.

Strategic Combination Brings Highly Innovative Late-Stage D-Fi Franchise Targeting Rare Diseases, with Orphan Drug-Designated Lead Indication in Dystrophic Epidermolysis Bullosa (DEB)

The Second Intangible Cultural Heritage and Healthy Living Conference

ATLANTA, GA, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (NASDAQ:IDAI), a global provider of AI-powered software solutions, today announced the signing of a Master Technology Subcontract Agreement with E&P Limited, the Ghanaian company leading the deployment of AFCAS, a public-private partnership with the Ghana National Fire Service to digitise fire compliance and safety certification nationwide. Under the agreement, Trust Stamp is appointed the sole and exclusive technology subcontractor for the AFCAS programme.

ROCKVILLE, Md., Oct. 30, 2026 (GLOBE NEWSWIRE) -- X-Energy, Inc. (Nasdaq: XE) (“X-energy” or “the Company”), a leading developer of advanced nuclear reactors and fuel technology, today announced the completion of the U.S. Nuclear Regulatory Commission’s (“NRC”) safety review for the initial deployment of X-energy’s Xe-100 high-temperature gas-cooled reactor (“HTGR”). The proposed Long Mott Generating Station would be the first grid-scale advanced nuclear reactor at an industrial facility in U.S. history, advancing in partnership with Dow (NYSE: DOW) under the U.S. Department of Energy’s Advanced Reactor Demonstration Program (“ARDP”).

- Revuforj is the first and only menin inhibitor that is approved for adults and children one year and older with R/R NPM1m AML and KMT2A translocated acute leukemia -

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- EVgo Inc. (Nasdaq: EVGO), one of the nation’s largest providers of public fast charging infrastructure for electric vehicles (EVs), today announced that it will release its third quarter financial results on Monday, November 9. This release will be followed by a webcast hosted by members of the EVgo management team at 9 a.m. ET (6 a.m. PT).

Starting at $29,000, the integrated system combines Supermicro hardware with VPP-accelerated VyOS LTS for IXPs, regional ISPs, and network operators that need 100 GbE routing without the integration burden

DURHAM, N.C., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on reversing or preventing blindness from inherited retinal disease, today announced new preclinical data for ATSN-301, a gene therapy for the treatment of Usher Syndrome Type 1B (USH1B). ATSN-301 combines Atsena’s proprietary dual AAV vector (DNA recombination) technology with its laterally spreading AAV.SPR capsid to reconstitute full-length MYO7A and deliver it to the macula without the need for foveal detachment. The data demonstrated robust, full-length MYO7A expression, a favorable safety margin and no observed adverse effect level (NOAEL) at the highest dose tested in a six-month GLP toxicology study. These results are detailed in a manuscript posted to bioRxiv and in a presentation at the European Society for Gene and Cell Therapy (ESGCT) 33rd Annual Congress, taking place October 27-30, 2026, in Hamburg, Germany.

Redesigned site brings together information on BGLC’s operating businesses, healthcare initiatives and public disclosures